AU677844B2 - Indole derivatives as CCK receptor antagonists - Google Patents

Indole derivatives as CCK receptor antagonists Download PDF

Info

Publication number
AU677844B2
AU677844B2 AU66633/94A AU6663394A AU677844B2 AU 677844 B2 AU677844 B2 AU 677844B2 AU 66633/94 A AU66633/94 A AU 66633/94A AU 6663394 A AU6663394 A AU 6663394A AU 677844 B2 AU677844 B2 AU 677844B2
Authority
AU
Australia
Prior art keywords
document
international
treatment
effective amount
therapeutically effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU66633/94A
Other languages
English (en)
Other versions
AU6663394A (en
Inventor
David Christopher Horwell
Janak Khimchand Padia
Martyn Clive Pritchard
Bharat Kalidas Trivedi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU6663394A publication Critical patent/AU6663394A/en
Application granted granted Critical
Publication of AU677844B2 publication Critical patent/AU677844B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
AU66633/94A 1994-03-10 1994-03-10 Indole derivatives as CCK receptor antagonists Ceased AU677844B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/002573 WO1995024389A1 (en) 1994-03-10 1994-03-10 Indole derivatives as cck receptor antagonists

Publications (2)

Publication Number Publication Date
AU6663394A AU6663394A (en) 1995-09-25
AU677844B2 true AU677844B2 (en) 1997-05-08

Family

ID=22242333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66633/94A Ceased AU677844B2 (en) 1994-03-10 1994-03-10 Indole derivatives as CCK receptor antagonists

Country Status (8)

Country Link
EP (1) EP0749422A1 (ja)
JP (1) JP3361100B2 (ja)
KR (1) KR100311329B1 (ja)
AU (1) AU677844B2 (ja)
FI (1) FI109689B (ja)
NO (1) NO307176B1 (ja)
NZ (1) NZ266052A (ja)
WO (1) WO1995024389A1 (ja)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010089A (en) * 1988-08-12 1991-04-23 Biomeasure, Inc. CCK antagonists and their use in treating gastrointestinal disorders
US5244915A (en) * 1990-08-31 1993-09-14 Warner-Lambert Company Amico acid derivatives cyclized at the c-terminal
US5264419A (en) * 1990-08-31 1993-11-23 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives

Also Published As

Publication number Publication date
KR970701694A (ko) 1997-04-12
NO307176B1 (no) 2000-02-21
JP3361100B2 (ja) 2003-01-07
WO1995024389A1 (en) 1995-09-14
FI109689B (fi) 2002-09-30
AU6663394A (en) 1995-09-25
FI963463A (fi) 1996-09-04
NO963775D0 (no) 1996-09-09
JPH09510440A (ja) 1997-10-21
KR100311329B1 (ko) 2002-02-28
FI963463A0 (fi) 1996-09-04
EP0749422A1 (en) 1996-12-27
NZ266052A (en) 1999-07-29
NO963775L (no) 1996-09-09

Similar Documents

Publication Publication Date Title
EP0405537B1 (en) N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives
KR100758609B1 (ko) 트라마돌 화합물 및 항경련 약물을 포함하는 조성물
AU658377B2 (en) Alpha-substituted tryptophane dipeptoid derivatives
EP0743853A1 (en) Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
IE841813L (en) Analgesic composition
EP0546108B1 (en) Pro-drugs for cck antagonists
US5792796A (en) Methods for treating anxiety and panic
EP0547178A1 (en) Novel cholecystokinin antagonists, their preparation and therapeutic use
US5846942A (en) Cholecystokinin antagonists, their preparation and therapeutic use
US5264419A (en) N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives
AU677844B2 (en) Indole derivatives as CCK receptor antagonists
KR100188055B1 (ko) Cck 길항제용 프로드러그
AU3006995A (en) Use of gabapentin in the treatment of anxiety and panic
WO1992004348A1 (en) N-substituted cycloalkyl and polycycloakyl polyhydro-β-carboline-phenylalanine-and phenethylamine derivatives
CA2184114A1 (en) Indole derivatives as cck receptor antagonists
JPH08504441A (ja) アザノルアダマンタン
AU651390C (en) Novel cholecystokinin antagonists, their preparation and therapeutic use
Clarke Annual Reports in Medicinal Chemistry
ADEMBRI et al. POSTER COMMUNICATIONS

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired